Role of prions in neuroprotection and neurodegeneration: A mechanism involving glutamate receptors?

Prion

Volumn 3, Issue 4, 2009, Pages

  Zamponi, Gerald W ^a   Stys, Peter K ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

Calcium; Glutamate; Neuroprotection; NMDA; NR2D

Indexed keywords

AMINO 5 PHOSPHONOVALERIC ACID; GLUTAMATE RECEPTOR; GLUTAMIC ACID; MEMANTINE; MYELIN; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PRION PROTEIN; UNCLASSIFIED DRUG; VALERIC ACID;

ALZHEIMER DISEASE; BOVINE SPONGIFORM ENCEPHALOPATHY; CEREBROVASCULAR ACCIDENT; CONFERENCE PAPER; CREUTZFELDT JAKOB DISEASE; DRUG RECEPTOR BINDING; NERVE DEGENERATION; NEUROPROTECTION; NONHUMAN; OLIGODENDROGLIA; PRION; PRION DISEASE; SEIZURE; ANIMAL; HUMAN; METABOLISM; REVIEW;

ANIMALS; HUMANS; NERVE DEGENERATION; PRION DISEASES; PRIONS; RECEPTORS, GLUTAMATE; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 74249090672     PISSN: 19336896     EISSN: 1933690X     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (39)

1. DeArmond SJ, Prusiner SB. Perspectives on prion biology, prion disease pathogenesis and pharmacologic approaches to treatment. Clin Lab Med 2003; 23:1-41.
2. Prusiner SB, Scott MR, DeArmond SJ, Cohen FE. Prion protein biology. Cell 1998; 93:337-48.
3. Moore RA, Taubner LM, Priola SA. Prion protein misfolding and disease. Curr Opin Struct Biol 2009; 19:14-22.
4. DeArmond SJ. Discovering the mechanisms of neurodegeneration in prion diseases. Neurochem Res 2004; 29:1979-98.
5. Linden R, Martins VR, Prado MA, Cammarota M, Izquierdo I, Brentani RR. Physiology of the prion protein. Physiol Rev 2008; 88:673-728.
6. Will RG, Alpers MP, Dormont D, Schonberger LB. Infectious and Sporadic Prion Diseases. In: "Prion biology and diseases", Prusiner SB, (ed.,) 2004; 13:629-72.
7. Fournier JG, Escaig-Haye F, Grigoriev V. Ultrastructural localization of prion proteins: physiological and pathological implications. Microsc Res Tech 2000; 50:76-88.
8. Salès N, Rodolfo K, Hässig R, Faucheux B, Di Giamberardino L, Moya KL. Cellular prion protein localization in rodent and primate brain. Eur J Neurosci 1998; 10:2464-71.
9. Sakudo A, Onodera T, Suganuma Y, Kobayashi T, Saeki K, Ikuta K. Recent advances in clarifying prion protein functions using knockout mice and derived cell lines. Mini Rev Med Chem 2006; 6:589-601.
10. Steele AD, Lindquist S, Aguzzi A. The prion protein knockout mouse: A phenotype under challenge. Prion 2007; 1:83-93.
11. Bueler H, Fischer M, Lang Y, Bluethmann H, Lipp HP, DeArmond SJ, et al. Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein. Nature 1992; 356:577-82.
12. Criado JR, Sanchez-Alavez M, Conti B, Giacchino JL, Wills DN, Henriksen SJ, et al. Mice devoid of prion protein have cognitive deficits that are rescued by reconstitution of PrP in neurons. Neurobiol Dis 2005; 19:255-65.
13. Collinge J, Whittington MA, Sidle KC, Smith CJ, Palmer MS, Clarke AR, Jefferys JG. Prion protein is necessary for normal synaptic function. Nature 1994; 370:295-7.
14. Maglio LE, Perez MF, Martins VR, Brentani RR, Ramirez OA. Hippocampal synaptic plasticity in mice devoid of cellular prion protein. Brain Res Mol Brain Res 2004; 131:58-64.
15. Maglio LE, Martins VR, Izquierdo I, Ramirez OA. Role of cellular prion protein on LTP expression in aged mice. Brain Res 2006; 1097:11-8.
16. Manson JC, Hope J, Clarke AR, Johnston A, Black C, MacLeod N. PrP gene dosage and long term potentiation. Neurodegeneration 1995; 4:113-4.
17. Curtis J, Errington M, Bliss T, Voss K, MacLeod N. Age-dependent loss of PTP and LTP in the hippocampus of PrP-null mice. Neurobiol Dis 2003; 13:55-62.
18. + currents. Neurosci Lett 1996; 209:49-52.
19. Colling SB, Khana M, Collinge J, Jefferys JG. Mossy fibre reorganization in the hippocampus of prion protein null mice. Brain Res 1997; 755:28-35.
20. Mallucci GR, Ratté S, Asante EA, Linehan J, Gowland I, Jefferys JG, Collinge J. Post-natal knockout of prion protein alters hippocampal CA1 properties, but does not result in neurodegeneration. EMBO J 2002; 21:202-10.
21. Baumann F, Tolnay M, Brabeck C, Pahnke J, Kloz U, Niemann HH, et al. Lethal recessive myelin toxicity of prion protein lacking its central domain. EMBO J 2007; 26:538-47.
22. Li A, Christensen HM, Stewart LR, Roth KA, Chiesa R, Harris DA. Neonatal lethality in transgenic mice expressing prion protein with a deletion of residues 105-125. EMBO J 2007; 26:548-58.
23. C. J Neurosci 2005; 25:4879-88.
24. Moore RC, Lee IY, Silverman GL, Harrison PM, Strome R, Heinrich C, et al. Ataxia in prion protein (PrP)-deficient mice is associated with upregulation of the novel PrP-like protein doppel. J Mol Biol 1999; 292:797-817.
25. Vassallo N, Herms J. Cellular prion protein function in copper homeostasis and redox signalling at the synapse. J Neurochem 2003; 86:538-44.
26. McLennan NF, Brennan PM, McNeill A, Davies I, Fotheringham A, Rennison KA, et al. Prion protein accumulation and neuroprotection in hypoxic brain damage. Am J Pathol 2004; 165:227-35.
27. C by adenovirus-mediated gene targeting reduces ischemic injury in a stroke rat model. J Neurosci 2005; 25:8967-77.
28. Spudich A, Frigg R, Kilic E, Kilic U, Oesch B, Raeber A, et al. Aggravation of ischemic brain injury by prion protein deficiency: role of ERK-1/-2 and STAT-1. Neurobiol Dis 2005; 20:442-9.
29. c) after focal cerebral ischemia and influence of lesion severity. Neurosci Lett 2004; 372:146-50.
30. Walz R, Amaral OE, Rockenbach IC, Roesler R, Izquierdo I, Cavalheiro EA, et al. Increased sensitivity to seizures in mice lacking cellular prion protein. Epilepsia 1999; 40:1679-82.
31. Rangel A, Burgaya F, Gavin R, Soriano E, Aguzzi A, Del Rio JA. Enhanced susceptibility of Prnp-deficient mice to kainate-induced seizures, neuronal apoptosis and death: Role of AMPA/kainate receptors. J Neurosci Res 2007; 85:2741-55.
32. Laurén J, Gimbel DA, Nygaard HB, Gilbert JW, Strittmatter SM. Cellular prion protein mediates impairment of synaptic plasticity by amyloid-beta oligomers. Nature 2009; 457:1128-32.
33. Arundine M, Tymianski M. Molecular mechanisms of glutamate-dependent neurodegeneration in ischemia and traumatic brain injury. Cell Mol Life Sci 2004; 61:657-68.
34. 2+ release. Trends Pharmacol Sci 1995; 16:356-9.
35. Olney JW, Collins RC, Sloviter RS. Excitotoxic mechanisms of epileptic brain damage. Adv Neurol 1986; 44:857-77.
36. Micu I, Jiang Q, Coderre E, Ridsdale A, Zhang L, Woulfe J, et al. NMDA receptors mediate Ca accumulation in central nervous system myelin during chemical ischemia. Nature 2006; 439:988-92.
37. Khosravani H, Zhang Y, Tsutsui S, Hameed S, Altier C, Hamid J, et al. Prion protein attenuates excitotoxicity by inhibiting NMDA receptors. J Cell Biol 2008; 181:551-65.
38. Cull-Candy SG, Leszkiewicz DN. Role of distinct NMDA receptor subtypes at central synapses. Sci STKE 2004; 255:16.
39. Riemer C, Burwinkel M, Schwarz A, Gültner S, Mok SW, Heise I, et al. Evaluation of drugs for treatment of prion infections of the central nervous system. J Gen Virol 2008; 89:594-7.